NeuroGenesis Bio Inc

NeuroGenesis Bio Inc. is a clinical-stage cellular therapy company focused on developing novel and effective treatments for neurodegenerative diseases. The company has established NG-01 as a proprietary method to transform a unique subpopulation of marrow-derived cells into bio-factories for sustained delivery of regenerative and neuroprotective proteins. By promoting myelin and neuronal regeneration, the NG-01 technology is optimized to treat neurodegenerative diseases such as progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). NG-01 has been studied extensively in several clinical trials including a successful double blind, randomized, placebo-controlled Phase 2 study for progressive MS, and two long term (up to...

Cell therapies,neurodegenerative diseases,and biotech

Neurogenesis bio inc operates in the Biotechnology research industry.

Neurogenesis bio inc's revenue is 11m - 100m

Neurogenesis bio inc has 11 - 50 employees.